NCT01592929

Brief Summary

In this study the possible changes in upper airway geometry induced by variations in the characteristics of the mouthpieces of inhalers will be evaluated with functional respiratory imaging (FRI) and Pharyngometry. The study population consists of 12 healthy male subjects. Different mouthpiece designs will be evaluated for each subject by using magnetic resonance imaging (MRI) scans. The results will help to identify the influence of the height, width, protrusion and resistance of the mouthpiece on upper airway geometry. Pharyngometry profiles of all subjects, whilst inhaling through different mouthpiece variants, in supine and upright position, will be completed. A computed tomography (CT) scan and a cone beam computed tomography (CBCT) scan of the upper airway will be taken to respectively compare the time dependence on 3D imaging with MRI and to provide a 3D image in an upright position. Dental impressions will be optically scanned to obtain a more accurate representation of the oral cavity, mainly in MRI.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2012

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 4, 2012

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 7, 2012

Completed
4 months until next milestone

Study Start

First participant enrolled

September 1, 2012

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2012

Completed
Last Updated

October 4, 2017

Status Verified

November 1, 2012

Enrollment Period

1 month

First QC Date

May 4, 2012

Last Update Submit

October 2, 2017

Conditions

Keywords

Functional Respiratory ImagingMagnetic Resonance ImagingMRIPharyngometryUpper AirwayMouthpiece of InhalerCone Beam Computed TomographyCBCTComputed TomographyCT

Outcome Measures

Primary Outcomes (1)

  • Changes in upper airway geometry by using MRI.

    The primary objective of this study is to evaluate with MRI-FRI the possible changes in upper airway geometry induced by using different mouthpieces.

    Within 20 days after day 1

Secondary Outcomes (1)

  • Changes in upper airway geometry by using pharyngometry in supine versus upright position.

    Within 20 days after day 1

Other Outcomes (2)

  • Evaluate time dependence on image upper airway by using CT scan

    At day 1

  • 3D image of upper airway in upright position by using CBCT scan

    At day 1

Interventions

11 MRI scans per subject will be taken, one for each mouthpiece design of an inhaler.

Also known as: MRI

Pharyngometry will be carried out in supine and upright position. 11 different mouthpieces will be evaluated in both positions.

One low dose CT scan of the upper airway will be taken. The scan will be taken at normal inhalation through a mouthpiece with moderate resistance.

Also known as: CT scan

One CBCT scan of the upper airway will be taken. The scan will be taken at normal respiration through a mouthpiece with moderate resistance.

Also known as: CBCT scan

Dental impressions will be taken. These will be optically scanned before registration in the 3D imaging modalities.

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male subject ≥ 18 years old
  • Written informed consent obtained
  • BMI ≥ 20 kg/m2 and \< 25 kg/m2
  • Height ≥ 175 cm and ≤ 185 cm
  • Subject must be able to understand and complete the protocol requirements, instructions and protocol-stated restrictions.

You may not qualify if:

  • Subject with claustrophobia
  • Subject with a history of surgery of the upper airway
  • Subject with an enlarged thyroid gland
  • Subject with intra-oral piercings
  • Subject with dental bracket
  • Subject with a pacemaker or another implant that is likely to interfere with the MRI procedure
  • Subject that is unlikely to comply with the protocol or unable to understand the nature, scope and possible consequences of the study
  • Subject who received any investigational new drug within the last 4 weeks prior to visit 1.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Antwerp University Hospital

Edegem, Antwerp, 2650, Belgium

Location

MeSH Terms

Interventions

Magnetic Resonance SpectroscopyDental Impression Technique

Intervention Hierarchy (Ancestors)

Spectrum AnalysisChemistry Techniques, AnalyticalInvestigative TechniquesTechnology, DentalDentistry

Study Officials

  • Wilfried De Backer, MD, PhD

    University Hospital, Antwerp

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 4, 2012

First Posted

May 7, 2012

Study Start

September 1, 2012

Primary Completion

October 1, 2012

Study Completion

October 1, 2012

Last Updated

October 4, 2017

Record last verified: 2012-11

Locations